Thus, further research has to clarify the role of the various AKT isoforms in bone metastasis of various cancer entities to assess the possibility of an isoform-specific AKT inhibition and to rule out possible adverse effects associated with panAKT inhibition. The gene discussed is AKT1; the disease is cancer.